Table 3.
2D Echocardiographic and MRI characteristics by CAD, N = 514**.
|
| ||||
|---|---|---|---|---|
| VARIABLE | OVERALL, N = 5141 | SIGNIFICANT CAD STATUS | P-VALUE2 | |
|
| ||||
| WITHOUT SIGNIFICANT CAD, N = 2041 | WITH SIGNIFICANT CAD, N = 3101 | |||
|
| ||||
| LVEDD | 54.0(47.0, 59.0) | 56.0(49.0, 62.0) | 52.0(47.0, 58.0) | <0.001 |
|
| ||||
| LVESD | 46.0(38.0, 52.0) | 48.0(40.0, 56.0) | 43.0(37.0, 50.0) | <0.001 |
|
| ||||
| Modified biplane simpson’s rule LVEF | 30.0(20.0, 35.0) | 25.0(20.0, 35.0) | 33.0(25.0, 35.0) | <0.001 |
|
| ||||
| LV mass index | 123.9(98.3, 153.1) | 129.2(102.8, 164.4) | 119.4(97.4, 143.2) | 0.042 |
|
| ||||
| Regional Wall motion | 244/514(47.5%) | 36/204(17.6%) | 208/310(67.1%) | <0.001 |
|
| ||||
| MRI | 46/494(9.3%) | 23/194(11.9%) | 23/300(7.7%) | 0.12 |
|
| ||||
| MRI-LVEF | 35.0(26.0, 40.0) | 34.0(23.8, 39.0) | 35.0(26.0, 45.5) | 0.55 |
|
| ||||
| MRI-RVEF | 47.0(34.5, 58.5) | 44.0(34.0, 48.0) | 57.0(38.0, 66.0) | 0.025 |
|
| ||||
| MRI-LGE | 35/45(77.8%) | 13/22(59.1%) | 22/23(95.7%) | 0.004 |
|
| ||||
| MRI-Ischaemic Cardiomyopathy | 25/45(55.6%) | 4/22(18.2%) | 21/23(91.3%) | <0.001 |
|
| ||||
1 Median (IQR); n/N(%).
2 Wilcoxon rank sum test; Pearson’s Chi-squared test; Fisher’s exact test.